Calcineurin inhibitors block the dephosphorylation of the nuclear factor of activated T-cells (NFAT), preventing its translocation to the nucleus and subsequent transcription of interleukin-2 and other cytokines. This action effectively reduces the immune response, making these drugs vital in managing conditions where immune suppression is desired.
